Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Montgomery Jr., J
Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes
The other works with a single weekly dose
Complete our waitlist form to be notified when FOXO4-DRI becomes available
Data availability The clinical study was conducted at three phase 1 clinical sites in the United States (Orange County Research Center, Anaheim Clinical Trials and Clinical Pharmacology of Miami) starting from August 2020 and completing in November 2022
Its currently in phase III clinical trials, which is the final stage before approval
US$ 27.20
US$ 26.43
US$ 20.68
US$ 26.55
